Nanxin Li

22.3k citations

158 papers · 9.8k indexed · 4 hit papers · h-index 36

Impact in

Biological Psychiatry top 0.05%
- Tryptophan and brain disorders
Behavioral Neuroscience top 0.2%
- Stress Responses and Cortisol

Papers in

Behavioral Neuroscience 14
- Stress Responses and Cortisol 14
Hematology 43
- Hemophilia Treatment and Research 17
- Iron Metabolism and Disorders 15

Co-authors: Michael Karin Ronald S. Duman George K. Aghajanian Mounira Banasr Xiaoyuan Li Boyoung Lee Jason M. Dwyer Masaaki Iwata
Journals: Blood (12 papers)Current Medical Research and Opinion (9 papers)Journal of Medical Economics (8 papers)Clinical Therapeutics (5 papers)Advances in Therapy (5 papers)
Partner nations: United States China United Kingdom

In The Last Decade

Nanxin Li

140 papers receiving 9.6k citations

Hit Papers

align trajectories log scale

Glutamate N-methyl-D-aspartate Receptor Antagonists Rapidly Reverse Behavioral and Synaptic Deficits Caused by Chronic Stress Exposure 2011 · 893 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2011 Biological Psychiatry
2010 Science
1999 PubMed
1999 The FASEB Journal

Peers

Countries citing papers authored by Nanxin Li

Since Specialization

Citations

This map shows the geographic impact of Nanxin Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nanxin Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nanxin Li more than expected).

Fields of papers citing papers by Nanxin Li

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nanxin Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nanxin Li. The network helps show where Nanxin Li may publish in the future.

Co-authors

The 25 scholars most cited alongside Nanxin Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Nanxin Li Line = papers co-authored together Nanxin Li links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Clinical Complications and Healthcare Resource Utilization Associated with Conventional Management of Sickle Cell Disease with Recurrent Vaso-occlusive Crises and Transfusion-Dependent β-Thalassemia in Germany PharmacoEconomics - Open ·C. Udeze, Nanxin Li, Colin Kunzweiler, Jessica Baldwin, Petra Tuzin, Sebastian Dietmar Zingel, Céline Vetter, Silvia Dombrowski, Elena Georgiadou-Schmidt, Aranzazu González del Alba, Roland Meisel	2025	0
2	Cognitive analysis and path construction of Chinese students’ mathematics cognitive process based on CDA Scientific Reports ·Xiaopeng Wu, Nanxin Li, Rongxiu Wu, Haibo Liu	2025	2
3	Health-related quality of life and economic impacts in adults with sickle cell disease with recurrent vaso-occlusive crises: findings from a prospective longitudinal real-world survey Quality of Life Research ·Jennifer Drahos, Adriana Boateng-Kuffour, Melanie Calvert, Ashley Valentine, Anthony Mason, Nanxin Li, Zahra Pakbaz, Farrukh Shah, Nick Ainsworth, Antony P. Martin	2025	0
4	Health-related quality of life and economic impacts in adults with transfusion-dependent β-thalassemia: findings from a prospective longitudinal real-world study Quality of Life Research ·Jennifer Drahos, Adriana Boateng-Kuffour, Melanie Calvert, Laurice Levine, Neelam Dongha, Nanxin Li, Zahra Pakbaz, Farrukh Shah, Nick Ainsworth, Antony P. Martin	2025	0
5	The Role of Tumor Stem Cells in Colorectal Cancer Drug Resistance Cancer Control ·Zhong Chen, Guojuan Wang, Min Guo, Naicheng Zhu, Xiudan Chen, Yuwei Yan, Nanxin Li, Wenyan Yu	2024	7
6	Clinical Burden and Health Care Resource Utilization Associated With Managing Sickle Cell Disease With Recurrent Vaso-occlusive Crises in England Clinical Therapeutics ·Chuka Udeze, Nelly F Ly, Fiona C. Ingleby, Steven Fleming, Sarah C. Conner, Jo Howard, Nanxin Li, Farrukh Shah	2024	0
7	Autophagy regulates apoptosis of colorectal cancer cells based on signaling pathways Discover Oncology ·Yuwei Yan, Wenyan Yu, Min Guo, Naicheng Zhu, Xiudan Chen, Nanxin Li, Chen Zhong, Guojuan Wang	2024	2
8	Improvements in Health-Related Quality of Life after Exagamglogene Autotemcel in Patients with Severe Sickle Cell Disease Blood ·Akshay Sharma, Haydar Frangoul, Markus Y. Mapara, Suzan Imren, Nanxin Li, Tina Liu, Jaime Rubin, Daoyuan Shi, William Hobbs, Stephan A. Grupp	2023	2
9	Association of factor expression levels with health-related quality of life and direct medical costs for people with haemophilia B Journal of Medical Economics ·Tom Burke, Anum Shaikh, Talaha M Ali, Nanxin Li, Randall Curtis, Daniel‐Anibal Garcia Diego, Michael Recht, Thomas Sannié, Mark W. Skinner, Jamie O’Hara	2022	4
10	Health care resource utilization and cost burden of hemophilia B in the United States Blood Advances ·Tyler W. Buckner, Iryna Bocharova, Kaitlin Hagan, Arielle G. Bensimon, Hongbo Yang, Eric Q. Wu, Eileen K. Sawyer, Nanxin Li	2021	20
11	Adult lifetime cost of hemophilia B management in the US: payer and societal perspectives from a decision analytic model Journal of Medical Economics ·Nanxin Li, Eileen K. Sawyer, Konrad Maruszczyk, Gregory F. Guzauskas, Marta T. Slomka, Tom Burke, Antony P. Martin, Jamie O’Hara, Matt Stevenson, Michael Recht	2021	8
12	Evidence of a disability paradox in patient‐reported outcomes in haemophilia Haemophilia ·Jamie O’Hara, Antony P. Martin, Diane J. Nugent, Michelle Witkop, Tyler W. Buckner, Mark W. Skinner, Brian O’Mahony, Brendan Mulhern, George Morgan, Nanxin Li, Eileen K. Sawyer	2021	33
13	Cost-Effectiveness Analysis of Recombinant Factor VIII Fc-Fusion Protein (rFVIIIFc) for the Treatment of Severe Hemophilia A in Italy Incorporating Real-World Dosing and Joint Health Data PharmacoEconomics - Open ·Ash Bullement, Samuel Thomas McMordie, Anthony J. Hatswell, Nanxin Li, Koo Wilson	2019	12
14	Clinical burden and healthcare resource utilization among patients with chronic hypoparathyroidism, overall and by adequately vs not adequately controlled disease: a multi-country chart review Journal of Medical Economics ·Kristina Chen, Alan Krasner, Nanxin Li, Cheryl Xiang, Todor Totev, Jipan Xie	2019	25
15	Dual ALK and CDK4/6 Inhibition Demonstrates Synergy against Neuroblastoma Clinical Cancer Research ·Andrew Wood, Kateryna Krytska, Hannah T. Ryles, Nicole R. Infarinato, Renata Sano, Theodore D. Hansel, Lori S. Hart, Frederick J. King, Timothy R. Smith, Edward Ainscow, Kathryn B. Grandinetti, Tove Tuntland, Sunkyu Kim, Giordano Caponigro, You He, Shiva Krupa, Nanxin Li, Jennifer L. Harris, Yaël P. Mossé	2016	67
16	Comparison of medical costs and healthcare resource utilization of post-menopausal women with HR+/HER2− metastatic breast cancer receiving everolimus-based therapy or chemotherapy: a retrospective claims database analysis Journal of Medical Economics ·Nanxin Li, Yanni Hao, Valerie Koo, Anna Fang, Miranda Peeples, Andrew Kageleiry, Eric Q. Wu, Annie Guérin	2016	4
17	Everolimus use and associated factors among post-menopausal women with hormonal receptor positive/human epidermal growth factor receptor 2 negative metastatic breast cancer Current Medical Research and Opinion ·Nanxin Li, Yanni Hao, Jipan Xie, Peggy L. Lin, Zhou Zhou, Yichen Zhong, James Signorovitch, Eric Q. Wu	2015	4
18	Physician experiences and preferences in the treatment of HR+/HER2− metastatic breast cancer in the United States: a physician survey Cancer Medicine ·Peggy L. Lin, Yanni Hao, Jipan Xie, Nanxin Li, Yichen Zhong, Zhou Zhou, James Signorovitch, Eric Q. Wu	2015	11
19	mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA Antagonists Science ·Nanxin Li, Boyoung Lee, Rongjian Liu, Mounira Banasr, Jason M. Dwyer, Masaaki Iwata, Xiaoyuan Li, George K. Aghajanian, Ronald S. Duman Hit paper breakdown →	2010	2240
20	Identification of NVP-TAE684, a potent, selective, and efficacious inhibitor of NPM-ALK Proceedings of the National Academy of Sciences ·Anna Galkin, Jonathan S. Melnick, Sung Joon Kim, Tami Hood, Nanxin Li, Lintong Li, Gang Xia, Ruo W. Steensma, Greg Chopiuk, Jiqing Jiang, Yongqin Wan, Peter Ding, Yi Liu, Fangxian Sun, Peter G. Schultz, Nathanael S. Gray, Markus Warmuth	2006	289

About Nanxin Li

Nanxin Li is a scholar working on Behavioral Neuroscience, Hematology, Biological Psychiatry, Genetics and Cancer Research, having authored 158 papers that have together received 9.8k indexed citations. Recurring topics across this work include Hemoglobinopathies and Related Disorders (23 papers), Hemophilia Treatment and Research (17 papers), Iron Metabolism and Disorders (15 papers), Stress Responses and Cortisol (14 papers), Advanced Breast Cancer Therapies (14 papers), Renal cell carcinoma treatment (11 papers), Neuroscience and Neuropharmacology Research (11 papers) and HER2/EGFR in Cancer Research (9 papers). The work is most often cited by research in Biological Psychiatry (2.8k citations), Behavioral Neuroscience (1.4k citations), Cellular and Molecular Neuroscience (2.7k citations), Pharmacology (2.5k citations) and Developmental Neuroscience (428 citations). Nanxin Li has collaborated with scholars based in United States, China and United Kingdom. Frequent co-authors include Michael Karin, Ronald S. Duman, George K. Aghajanian, Mounira Banasr, Xiaoyuan Li, Boyoung Lee, Jason M. Dwyer, Masaaki Iwata, Rongjian Liu and Rong-Jian Liu. Their work appears in journals such as Blood, Current Medical Research and Opinion, Journal of Medical Economics, Clinical Therapeutics and Advances in Therapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact